Skip to content
Recall Observatory FDA recall evidence

Device product

BD GeneOhm VanR Assay , Catalog # 441250, 5 box tests labeled in part***GeneOhm Sciences Canada, Inc., 2555 boul, du Parc-Technologique, Quebec, QC, Canada G1P 4S5***. The BD GeneOhm VanR Assay is a qualitative in vitro test for the rapid detection of vancomycin-resistance (vanA and vanB) genes directly from perianal or rectal swabs. The BD GeneOhm VanR Assay detects the presence of the vanA and vanB genes that can be associated with vancomycin-resistant enterococci (VRE). The assay is performed on an automated real-time PCR instrument with perianal or rectal swabs from individuals at risk for VRE colonization. The BD GeneOhm VanR Assay can be used as an aid to identify, prevent and control vancomycin-resistant colonization in healthcare settings. The BD GeneOhm VanR Assay is not intended to diagnose VRE infections nor to guide or monitor treatment for VRE infections. Concomitant cultures are necessary to recover organisms for epidemiological typing, susceptibility testing and for further confirmatory identification.

Z-2320-2012

May 22, 2012

Class II

Product summary

Firm
Becton Dickinson & Co.
Event
Event 62505
Status
Terminated
Classification
Class II
Quantity
5 kits
Official record key
device-enforcement:Z-2320-2012

Official wording

Reason: Leakage in Cepheid SmartCycler reaction tubes.

Code information: Lot/ Exp. 05T11042 2012-04-30 (ONLY SOLD IN EUROPE)

Distribution pattern: Nationwide Distribution including CA, DE, FL, GA, IL, IN, KS, KY, ME, MT, NC, NJ, NM, NY, OH, OK, PA, SC, TX, VA, WA, WI, and WV.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Leakage in Cepheid SmartCycler reaction tubes.